CoChat

Benefits, limits, and risks of ChatGPT in medicine

Open access
Tangsrivimol, Jonathan A., Darzidehkalani, Erfan, Virk, Hafeez Ul Hassan, Wang, Zhen, Egger, Jan, Wang, Michelle, Hacking, Sean, Glicksberg, Benjamin S., Strauss, Markus, Krittanawong, Chayakrit · 2025 · Frontiers in Artificial Intelligence
Cited by 76

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

ChatGPT represents a transformative technology in healthcare, with demonstrated impacts across clinical practice, medical education, and research. Studies show significant efficiency gains, including 70% reduction in administrative time for discharge summaries and achievement of medical professional-level performance on standardized tests (60% accuracy on USMLE, 78.2% on PubMedQA). ChatGPT offers personalized learning platforms, automated scoring, and instant access to vast medical knowledge in medical education, addressing resource limitations and enhancing training efficiency. It streamlines clinical workflows by supporting triage processes, generating discharge summaries, and alleviating administrative burdens, allowing healthcare professionals to focus more on patient care. Additionally, ChatGPT facilitates remote monitoring and chronic disease management, providing personalized advice, medication reminders, and emotional support, thus bridging gaps between clinical visits. Its ability to process and synthesize vast amounts of data accelerates research workflows, aiding in literature reviews, hypothesis generation, and clinical trial designs. This paper aims to gather and analyze published studies involving ChatGPT, focusing on exploring its advantages and disadvantages within the healthcare context. To aid in understanding and progress, our analysis is organized into six key areas: (1) Information and Education, (2) Triage and Symptom Assessment, (3) Remote Monitoring and Support, (4) Mental Healthcare Assistance, (5) Research and Decision Support, and (6) Language Translation. Realizing ChatGPT’s full potential in healthcare requires addressing key limitations, such as its lack of clinical experience, inability to process visual data, and absence of emotional intelligence. Ethical, privacy, and regulatory challenges further complicate its integration. Future improvements should focus on enhancing accuracy, developing multimodal AI models, improving empathy through sentiment analysis, and safeguarding against artificial hallucination. While not a replacement for healthcare professionals, ChatGPT can serve as a powerful assistant, augmenting their expertise to improve efficiency, accessibility, and quality of care. This collaboration ensures responsible adoption of AI in transforming healthcare delivery. While ChatGPT demonstrates significant potential in healthcare transformation, systematic evaluation of its implementation across different healthcare settings reveals varying levels of evidence quality–from robust randomized trials in medical education to preliminary observational studies in clinical practice. This heterogeneity in evidence quality necessitates a structured approach to future research and implementation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/frai.2025.1518049

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 76

Metadata

Authors
Tangsrivimol, J. A., Darzidehkalani, E., Virk, H. U. H., Wang, Z., Egger, J., Wang, M., Hacking, S., Glicksberg, B. S., Strauss, M., & Krittanawong, C.
Venue
Frontiers in Artificial Intelligence
Published
2025-01-30
Volume
8
Pages
1518049-1518049
ISSN
2624-8212 (ISSN-L)
OpenAlex
W4407002549
Cited by
76
References
42
FWCI
15.56
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Benefits, limits, and risks of ChatGPT in medicine. https://app.cochat.ai/papers/10.3389/frai.2025.1518049
The paper
Tangsrivimol, J. A., Darzidehkalani, E., Virk, H. U. H., Wang, Z., Egger, J., Wang, M., Hacking, S., Glicksberg, B. S., Strauss, M., & Krittanawong, C. (2025). Benefits, limits, and risks of ChatGPT in medicine. Frontiers in Artificial Intelligence. https://doi.org/10.3389/frai.2025.1518049

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.